☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Long-Acting
ViiV Healthcare Present Results of Long- Acting Cabotegravir and Rilpivirine in P-IIIb ATLAS-2M Study for HIV at CROI 2021
March 8, 2021
PharmaShots Interview: ViiV Healthcare's Kimberly Smith Shares Insight on Data of Long-Acting Cabotegravir and Rilpivirine Present...
December 28, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.